| Time Since Dose | % of Dose | Status |
|---|
Metformin — sold under the brand name Glucophage — is the world's most widely prescribed medication for type 2 diabetes. It works by reducing glucose production in the liver and improving insulin sensitivity, and is typically taken once or twice daily with meals.
How Long Does Metformin Stay in Your System?
After a single dose, metformin's plasma concentration follows a half-life of approximately 6.2 hours. After 5 half-lives (roughly 31 hours), less than 3% of the dose remains in your bloodstream. In practice, metformin is considered essentially eliminated within 24–48 hours of the last dose in people with normal kidney function.
However, metformin has an important pharmacokinetic quirk: it distributes extensively into red blood cells, where its half-life is significantly longer — approximately 17.6 hours. This means complete clearance from all body compartments can take somewhat longer than the plasma half-life alone suggests.
What Affects How Long Metformin Stays in Your System?
- Kidney function — Metformin is excreted unchanged by the kidneys. Impaired renal function dramatically slows clearance and can cause dangerous accumulation. Metformin is contraindicated in severe kidney disease (eGFR < 30 mL/min/1.73m²).
- Age — Older adults tend to have reduced kidney function, which slows metformin clearance. Dose adjustments are often needed.
- Dose form — Extended-release metformin (Glucophage XR) is absorbed more slowly and has a flatter, more prolonged concentration profile than immediate-release tablets.
- Hydration status — Dehydration reduces kidney perfusion and can slow metformin elimination.
- Iodinated contrast media — Metformin is typically stopped before procedures using contrast dye due to a small risk of lactic acidosis when kidney function is temporarily impaired.
Why Is Metformin Stopped Before Surgery?
Metformin is commonly held for 48 hours before major surgery or procedures involving iodinated contrast media. This is because anaesthesia and surgical stress can temporarily reduce kidney perfusion, slowing metformin clearance and raising the (rare but serious) risk of lactic acidosis. Given metformin's 24–48 hour clearance time, stopping it 48 hours before a procedure ensures it is fully eliminated beforehand.
Metformin is not metabolised in humans and is excreted essentially unchanged in the urine by active tubular secretion as well as glomerular filtration. Its plasma elimination half-life is roughly 4 to 9 hours, but metformin concentrates inside red blood cells, where it has a much longer apparent half-life — a finding documented in the FDA prescribing information for Glucophage and in peer-reviewed pharmacokinetic studies indexed on the NIH's PubMed database. Because clearance is renal, the U.S. FDA, the U.K. NHS and the European Medicines Agency all advise reviewing kidney function before starting metformin and periodically thereafter, and the FDA label carries a boxed warning regarding the rare but serious risk of lactic acidosis.
Sources cross-checked: U.S. FDA prescribing information (DailyMed), U.K. NHS medicines information, and additional official references from the European Medicines Agency, NIH MedlinePlus / LiverTox, the WHO Model List of Essential Medicines, or the American Thyroid Association, depending on the medication. This page is general educational information only and is not medical advice.